Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04734535 · ClinicalTrials.gov registry record · NA
Evaluation of Safety of HEMOBLAST Bellows in Spine Surgery
A NA study of Surgical Bleeding, sponsored by Dilon Technologies.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 5
- Study locations
NCT04734535 is a NA study of Surgical Bleeding that has completed, run by Dilon Technologies. The registered enrollment target is 60 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT04734535, a NA study of Surgical Bleeding, has completed, sponsored by Dilon Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this clinical investigation in open, elective, spine surgery is to collect data to support the removal of the neurosurgical exclusion from the currently approved indication for the use of HEMOBLAST™ Bellows. This study is primarily designed to assess safety of the device for use in spine surgery, although efficacy information will also be captured and reported.
Conditions Studied
Interventions
- DEVICE HEMOBLAST™ Bellows
- DEVICE absorbable gelatin sponge with thrombin
Study Locations (5)
California
- University of Southern California - Los Angeles
Indiana
- Indiana Spine Group - Carmel
Maryland
- Johns Hopkins Bayview Medical Center - Baltimore
Massachusetts
- Massachusetts General Hospital - Boston
Virginia
- Spectrum Medical Inc - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2024-02-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04734535
The ClinicalTrials.gov registry entry for NCT04734535 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dilon Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Surgical Bleeding appearing as the primary indexed condition, and to 2 interventions - of which HEMOBLAST™ Bellows is the first listed.
NCT04734535 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Indiana, Maryland.
Frequently Asked Questions
What is clinical trial NCT04734535 about?
NCT04734535 is a clinical study titled "Evaluation of Safety of HEMOBLAST Bellows in Spine Surgery". The purpose of this clinical investigation in open, elective, spine surgery is to collect data to support the removal of the neurosurgical exclusion from the currently approved indication for the use of HEMOBLAST™ Bellows. This study is primarily designed to assess safety of the device for use in sp...
What is the current status of trial NCT04734535?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-03-08. Estimated completion is 2024-02-05.
What conditions does trial NCT04734535 study?
This clinical trial studies the following conditions: Surgical Bleeding.
What interventions are being tested in trial NCT04734535?
The interventions under investigation include: HEMOBLAST™ Bellows (DEVICE), absorbable gelatin sponge with thrombin (DEVICE).
Who is sponsoring clinical trial NCT04734535?
This trial is sponsored by Dilon Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04734535 being conducted?
This trial has 5 study locations across California, Indiana, Maryland, Massachusetts, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.